비교리스트

 카트 문의
시장보고서
상품코드
1565015

세계의 종양 정보 시스템 시장

Oncology Information Systems
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

종양 정보 시스템 세계 시장 규모는 2030년까지 64억 달러에 달할 것으로 전망

2023년 42억 달러로 추정되는 종양 정보 시스템 세계 시장은 2023년부터 2030년까지 연평균 6.1% 성장하여 2030년에는 64억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 '소프트웨어'는 CAGR 6.7%를 기록하여 분석 기간 종료 시점에 55억 달러에 도달할 것으로 예상됩니다. 서비스 분야의 성장률은 분석 기간 동안 CAGR 3.2%로 추정됩니다.

미국 시장은 12억 달러, 중국 CAGR 5.7%로 성장 전망

미국의 종양 정보 시스템 시장은 2023년 12억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 5.7%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년에는 9억 9,470만 달러 시장 규모를 형성할 것으로 예측됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 5.7%와 4.7%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 4.8%의 성장률을 보일 것으로 예상됩니다.

세계 종양 정보 시스템 시장 - 주요 동향 및 촉진요인 정리

종양 정보 시스템이란 무엇이며, 왜 중요한가?

종양 정보 시스템(OIS)은 종합적인 암 치료를 관리하기 위해 설계된 전문 디지털 플랫폼입니다. 이 시스템은 환자 데이터 관리, 치료 계획, 임상 워크플로우, 의사결정 지원 도구 등 다양한 기능을 단일 솔루션으로 통합합니다. OIS는 환자 기록의 문서화를 간소화하고, 치료 프로토콜을 추적하고, 다학제 팀 간의 커뮤니케이션을 개선함으로써 암 치료의 질과 효율성을 높이는 데 중요한 역할을 합니다. 이러한 시스템은 병원, 암 치료 센터, 연구 기관 등에서 널리 채택되어 정밀의료를 촉진하고, 환자 결과를 모니터링하며, 진화하는 치료 가이드라인을 준수할 수 있도록 돕습니다. 전 세계적으로 암 발병률이 증가함에 따라 종양 정보 시스템은 이 복잡한 질병을 퇴치하는 데 필수적인 도구가 되고 있습니다.

기술의 발전은 어떻게 종양 정보 시스템을 형성하고 있는가?

기술의 발전은 진화하는 종양 정보 시스템의 핵심으로, 치료 계획, 데이터 분석 및 환자 치료의 획기적인 개선을 주도하고 있습니다. 가장 혁신적인 혁신 중 하나는 인공지능(AI)과 머신러닝 알고리즘의 통합으로, 방대한 양의 환자 데이터를 분석하고 치료 결과를 예측하여 임상의가 개인화된 치료 계획을 수립할 수 있도록 돕습니다. 또한, OIS 플랫폼은 상호 운용성을 강화하여 서로 다른 의료 시스템, 전자 의료 기록(EHR), 의료 영상 기술 간의 원활한 데이터 교환을 가능하게 합니다. 클라우드 기반 종양 정보 시스템도 접근성, 확장성, 데이터 보안을 강화하면서 인기를 끌고 있습니다. 원격 의료가 확산됨에 따라 OIS 플랫폼은 원격 환자 모니터링 도구를 통합하여 종양 전문의가 환자의 경과를 실시간으로 추적하고 그에 따라 치료 프로토콜을 조정할 수 있게 해줍니다.

보건의료 분야에서 종양 정보 시스템 도입이 증가하는 이유는 무엇일까?

전 세계적으로 암 발병률이 증가함에 따라 효율적이고 종합적인 암 치료 관리 시스템에 대한 수요가 증가하고 있으며, 이에 따라 OIS의 채택이 증가하고 있습니다. 이러한 시스템은 다양한 전문가들 간의 협력이 중요한 복잡하고 다학제적인 암 치료에 특히 유용합니다. 헬스케어 산업이 가치 기반 치료로 전환하는 가운데, 종양 정보 시스템은 의료 제공업체가 치료 결과, 환자 순응도, 전체 의료 비용을 추적하는 데 도움을 주어 보다 비용 효율적이고 결과 중심의 암 치료에 기여할 수 있습니다. 또한, 개인별 유전자 프로파일에 따라 맞춤 치료하는 정밀 종양학에 대한 관심이 높아지면서 개인별 맞춤 치료 계획에 필요한 방대한 유전자 및 임상 데이터를 관리하기 위해 OIS에 크게 의존하고 있습니다. 통합함으로써 치료의 정확성과 효율성을 더욱 높일 수 있습니다.

종양 정보 시스템 시장의 성장을 가속하는 요인은?

종양 정보 시스템 시장의 성장은 전 세계 암 부담 증가, 암 치료 관리의 협력적 관리에 대한 수요 증가, AI 기반 치료 계획, 클라우드 기반 플랫폼, 원격 모니터링 도구와 같은 기술 발전으로 인해 OIS의 기능성과 접근성이 크게 향상되어 현대 암 치료에 필수적인 요소로 부상하고 있습니다. 접근성이 크게 향상되어 현대 암 진료에 필수적인 요소로 자리 잡고 있습니다. 정밀의료와 맞춤 암 치료로의 전환도 중요한 촉진제이며, OIS는 유전체학 및 맞춤 치료 계획과 관련된 복잡한 데이터 세트를 관리하는 데 필수적입니다. 또한, 의료 서비스 제공업체들은 문서화, 치료 프로토콜 및 환자 안전에 대한 규제 요건을 충족하기 위해 OIS를 점점 더 많이 채택하고 있습니다. 종합적인 암 치료에 대한 수요가 지속적으로 증가함에 따라 OIS 플랫폼은 암 치료에 필수적인 요소로 자리 잡고 있으며, 이 시장의 지속적인 성장을 주도하고 있습니다.

조사 대상 기업 예시(주목받는 43개 기업)

  • Accuray, Inc.
  • Cerner Corporation
  • Elekta AB
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • RAYSEARCH Laboratories AB
  • Varian Medical Systems, Inc.

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 기타 유럽
    • 아시아태평양
    • 기타 지역

    제4장 경쟁

    LSH 24.10.08

    Global Oncology Information Systems Market to Reach US$6.4 Billion by 2030

    The global market for Oncology Information Systems estimated at US$4.2 Billion in the year 2023, is expected to reach US$6.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 3.2% CAGR over the analysis period.

    The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 5.7% CAGR

    The Oncology Information Systems market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$994.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

    Global Oncology Information Systems Market – Key Trends & Drivers Summarized

    What Are Oncology Information Systems and Why Are They Crucial?

    Oncology information systems (OIS) are specialized digital platforms designed to manage comprehensive cancer care. These systems integrate various functions, including patient data management, treatment planning, clinical workflows, and decision support tools, into a single solution. By streamlining the documentation of patient records, tracking treatment protocols, and improving communication between multidisciplinary teams, OIS play a vital role in enhancing the quality and efficiency of oncology care. These systems are widely adopted by hospitals, cancer treatment centers, and research institutions, where they facilitate precision medicine, monitor patient outcomes, and ensure compliance with evolving treatment guidelines. With the increasing incidence of cancer globally, oncology information systems are becoming an essential tool in the fight against this complex disease.

    How Are Technological Advancements Shaping Oncology Information Systems?

    Technological advancements are at the core of the evolving oncology information systems landscape, driving significant improvements in treatment planning, data analytics, and patient care. One of the most transformative innovations has been the integration of artificial intelligence (AI) and machine learning algorithms, which assist clinicians in developing personalized treatment plans by analyzing vast amounts of patient data and predicting outcomes. Additionally, OIS platforms are becoming more interoperable, allowing seamless data exchange between different healthcare systems, electronic health records (EHR), and medical imaging technologies. Cloud-based oncology information systems are also gaining traction, offering enhanced accessibility, scalability, and data security. As telemedicine becomes more prevalent, OIS platforms are integrating remote patient monitoring tools, enabling oncologists to track patient progress in real time and adjust treatment protocols accordingly.

    Why Is the Adoption of Oncology Information Systems Increasing in Healthcare?

    The rising incidence of cancer worldwide has increased the demand for efficient and comprehensive cancer care management systems, driving the adoption of OIS. These systems are particularly valuable in complex, multidisciplinary cancer treatments, where coordination between various specialists is critical. As the healthcare industry shifts towards value-based care, oncology information systems help providers track treatment outcomes, patient adherence, and overall healthcare costs, contributing to more cost-effective and outcome-driven cancer care. Moreover, the growing emphasis on precision oncology, which tailors treatments to the individual’s genetic profile, relies heavily on OIS to manage the vast amounts of genetic and clinical data required for personalized treatment plans. The integration of OIS with radiation therapy and chemotherapy systems further enhances treatment accuracy and efficiency.

    What Factors Are Driving Growth in the Oncology Information Systems Market?

    The growth in the oncology information systems market is driven by several factors, including the rising global cancer burden and the increasing need for coordinated cancer care management. Technological advancements, such as AI-driven treatment planning, cloud-based platforms, and remote monitoring tools, are significantly improving the functionality and accessibility of OIS, making them essential in modern oncology practices. The shift toward precision medicine and personalized cancer therapies is another key driver, as OIS are indispensable for managing the complex data sets associated with genomics and individualized treatment plans. Additionally, healthcare providers are increasingly adopting OIS to meet regulatory requirements for documentation, treatment protocols, and patient safety. As the demand for comprehensive cancer care continues to grow, OIS platforms are becoming a vital component of cancer treatment, driving sustained growth in this market.

    Select Competitors (Total 43 Featured) -

    • Accuray, Inc.
    • Cerner Corporation
    • Elekta AB
    • Epic Systems Corporation
    • Flatiron Health, Inc.
    • Koninklijke Philips NV
    • McKesson Corporation
    • RAYSEARCH Laboratories AB
    • Varian Medical Systems, Inc.

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • World Market Trajectories
      • Global Economic Update
      • Oncology Information Systems - Global Key Competitors Percentage Market Share in 2024 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Growing Focus on Personalized Cancer Treatment Drives Demand for Advanced Oncology Information Systems (OIS)
      • Increased Adoption of Electronic Health Records (EHR) Integration Expands Addressable Market for OIS Solutions
      • Rising Cancer Incidence Globally Spurs Growth in Oncology Information Systems Deployment Across Healthcare Providers
      • Advancements in AI-Driven Decision Support Systems Propel Growth of Oncology Information Systems for Treatment Planning
      • Value-Based Care Models Strengthen the Business Case for Comprehensive Oncology Information Systems
      • Increased Focus on Precision Medicine Accelerates Demand for Data-Driven Oncology Information Systems
      • Growing Adoption of Cloud-Based Oncology Information Systems Enhances Scalability and Access
      • Rising Need for Multidisciplinary Care Coordination Drives Demand for Integrated Oncology Information Systems
      • Advances in Genomic Data Integration in OIS Platforms Propel Growth in Molecular Oncology Diagnostics
      • Growing Emphasis on Patient-Centric Care Models Expands the Addressable Market for Oncology Information Systems
      • Increasing Utilization of Telemedicine in Cancer Care Spurs Growth in Cloud-Enabled Oncology Information Systems
      • Rising Need for Advanced Reporting and Analytics in Oncology Research and Clinical Trials Generates Demand for OIS Solutions
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Oncology Information Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
      • TABLE 2: World Recent Past, Current & Future Analysis for Oncology Information Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 3: World Historic Review for Oncology Information Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 4: World 16-Year Perspective for Oncology Information Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
      • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 7: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 10: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 11: World Recent Past, Current & Future Analysis for Medical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 12: World Historic Review for Medical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 13: World 16-Year Perspective for Medical Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 14: World Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 15: World Historic Review for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 16: World 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 17: World Recent Past, Current & Future Analysis for Surgical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 18: World Historic Review for Surgical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 19: World 16-Year Perspective for Surgical Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Oncology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 21: World Historic Review for Hospitals & Oncology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 22: World 16-Year Perspective for Hospitals & Oncology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 23: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 24: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 25: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 29: USA Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 30: USA Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 31: USA 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 33: USA Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 34: USA 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 36: USA Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 37: USA 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • CANADA
      • TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 39: Canada Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 40: Canada 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 42: Canada Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 43: Canada 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 44: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 45: Canada Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 46: Canada 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • JAPAN
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 48: Japan Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 49: Japan 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 50: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 51: Japan Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 52: Japan 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 53: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 54: Japan Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 55: Japan 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • CHINA
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 56: China Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 57: China Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 58: China 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 59: China Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 60: China Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 61: China 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 62: China Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 63: China Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 64: China 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • EUROPE
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 65: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 66: Europe Historic Review for Oncology Information Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 67: Europe 16-Year Perspective for Oncology Information Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
      • TABLE 68: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 69: Europe Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 70: Europe 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 71: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 72: Europe Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 73: Europe 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 74: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 75: Europe Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 76: Europe 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • FRANCE
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 77: France Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 78: France Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 79: France 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 80: France Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 81: France Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 82: France 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 83: France Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 84: France Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 85: France 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • GERMANY
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 86: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 87: Germany Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 88: Germany 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 89: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 90: Germany Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 91: Germany 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 92: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 93: Germany Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 94: Germany 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • ITALY
      • TABLE 95: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 96: Italy Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 97: Italy 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 98: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 99: Italy Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 100: Italy 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 101: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 102: Italy Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 103: Italy 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • UNITED KINGDOM
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 104: UK Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 105: UK Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 106: UK 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 107: UK Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 108: UK Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 109: UK 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 110: UK Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 111: UK Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 112: UK 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • REST OF EUROPE
      • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 114: Rest of Europe Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 115: Rest of Europe 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 117: Rest of Europe Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 118: Rest of Europe 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 120: Rest of Europe Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 121: Rest of Europe 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • ASIA-PACIFIC
      • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 123: Asia-Pacific Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 124: Asia-Pacific 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 126: Asia-Pacific Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 127: Asia-Pacific 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 129: Asia-Pacific Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 130: Asia-Pacific 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • REST OF WORLD
      • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 132: Rest of World Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 133: Rest of World 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
      • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 135: Rest of World Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 136: Rest of World 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
      • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 138: Rest of World Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 139: Rest of World 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030

    IV. COMPETITION

    • 비교리스트
    0 건의 상품을 선택 중
    상품 비교하기
    전체삭제